T

TC BioPharm Limited

81 employees

TC BioPharm develops safer, cheaper, consistent, and durable CAR-T drugs for hematological and solid tumors.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Health Care
Cancer Immonotherapy
Therapeutics
Stratified Medicine
Regenerative Medicine
Clinical Grade Cell Therapy

Date founded

2014

Funding rounds raised

Total raised

$16M

from 6 investors over 6 rounds

T

TC BioPharm Limited raised undisclosed on January 19, 2021

Investors: Renaissance Capital Partners

T

TC BioPharm Limited raised $2.3M on December 2, 2020

Investors: Crowdcube

T

TC BioPharm Limited raised undisclosed on October 31, 2019

Investors: Renaissance Capital Partners

T

TC BioPharm Limited raised $3.7M on January 6, 2018

Investors: Scottish Enterprise

T

TC BioPharm Limited raised $16M on December 7, 2017

Investors: Renaissance Capital Partners and bluebird bio

FAQ